S. Sharma

Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

Savita Sankar, Russell Bell, Bret J. Stephens et al. · Oncogene · 2012 · 166 citations · Full text

Tumor Biology, Transcriptional Regulation, Ewing Sarcoma +6

Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells

Warren Fiskus, S. Sharma, Saikat Saha et al. · Leukemia · 2014 · 95 citations · Full text

Hematological Malignancy, Oncology, Histone Deacetylase Inhibitor +9

BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells

Dyana T. Saenz, Warren Fiskus, Taghi Manshouri et al. · Leukemia · 2016 · 89 citations · Full text

Hematological Malignancy, Inhibitor-based Combinations, Bet Protein +8

A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer

Ignacio Garrido‐Laguna, Kimberly McGregor, Mark Wade et al. · Investigational New Drugs · 2013 · 64 citations

Phase I/ii Study, Medicine, Pharmacology +5

Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells

Sumati Gupta, Alexis Weston, Jared Bearrs et al. · Prostate Cancer and Prostatic Diseases · 2016 · 46 citations · Full text